[HTML][HTML] Cytokine storm and immunomodulatory therapy in COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies
M Zhao - International journal of antimicrobial agents, 2020 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus-2, the causative agent of coronavirus
disease 2019 (COVID-19), was declared a pandemic by the World Health Organization on …
disease 2019 (COVID-19), was declared a pandemic by the World Health Organization on …
Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies
M Zhao - 2020 - expeditiorepositorio.utadeo.edu.co
Severe acute respiratory syndrome coronavirus-2, the causative agent of coronavirus
disease 2019 (COVID-19), was declared a pandemic by the World Health Organization on …
disease 2019 (COVID-19), was declared a pandemic by the World Health Organization on …
Cytokine storm and immunomodulatory therapy in COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies.
M Zhao - 2020 - cabidigitallibrary.org
Highlights:* Discussion of the role of immunomodulatory agents to reduce the cytokine storm
in severe cases of COVID-19.* Potential immunomodulatory agents currently used in the …
in severe cases of COVID-19.* Potential immunomodulatory agents currently used in the …
Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies.
M Zhao - International Journal of Antimicrobial Agents, 2020 - europepmc.org
Severe acute respiratory syndrome coronavirus-2, the causative agent of coronavirus
disease 2019 (COVID-19), was declared a pandemic by the World Health Organization on …
disease 2019 (COVID-19), was declared a pandemic by the World Health Organization on …
Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies
M Zhao - International journal of antimicrobial agents, 2020 - pubmed.ncbi.nlm.nih.gov
• Discussion of the role of immunomodulatory agents to reduce the cytokine storm in severe
cases of COVID-19.• Potential immunomodulatory agents currently used in the treatment of …
cases of COVID-19.• Potential immunomodulatory agents currently used in the treatment of …
Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies.
M Zhao - International Journal of Antimicrobial Agents, 2020 - europepmc.org
Severe acute respiratory syndrome coronavirus-2, the causative agent of coronavirus
disease 2019 (COVID-19), was declared a pandemic by the World Health Organization on …
disease 2019 (COVID-19), was declared a pandemic by the World Health Organization on …